After an assessment of the documentation provided by the MAH and an evaluation of the current EU- wide clinical practices relating to the use of Zocord, the following was considered to be the most suitable harmonised Section 4.3 Contraindications, the text in the harmonised SPC is not so dissimilar to the currently approved SPCs that it will significantly change clinical practices: